v3.25.4
Schedule II Valuation and Qualifying Accounts (Notes)
 12 Months Ended
Dec. 31, 2025
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure
(a) 1.
Financial Statements
The following Consolidated Financial Statements are set forth in Part II, Item 8 of this report.
Report of Independent Registered Public Accounting Firm
Consolidated Statements of Earnings for 2025, 2024 and 2023
Consolidated Statements of Comprehensive Income for 2025, 2024 and 2023
Consolidated Balance Sheets on 2025 and 2024
Consolidated Statements of Shareholders’ Equity for 2025, 2024 and 2023
Consolidated Statements of Cash Flows for 2025, 2024 and 2023
Notes to Consolidated Financial Statements
(a) 2.
Financial Statement Schedules
The Consolidated Financial Statement schedule of Stryker Corporation and its subsidiaries is:
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
 
 
Additions
Deductions
 
Description
Balance at
Beginning
of Period
Charged to
Costs &
Expenses
Uncollectible
Amounts
Written Off,
Net of
Recoveries
Effect of
Changes in
Foreign
Currency
Exchange
Rates
Balance
at End
of Period
DEDUCTED FROM ASSET ACCOUNTS
Allowance for Doubtful Accounts:
Year ended December 31, 2025
$213
$95
$91
$1
$216
Year ended December 31, 2024
$182
$69
$36
$2
$213
Year ended December 31, 2023
$154
$69
$40
$1
$182
All other schedules for which provision is made in the applicable accounting regulation of the United States Securities and
Exchange Commission are not required under the related instructions or are inapplicable and, therefore, have been omitted.
(a) 3.
Exhibits